| Symbol | NPCE |
|---|---|
| Name | NEUROPACE INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA 94043 |
| Telephone | 6502372700 |
| Fax | — |
| — | |
| Website | https://www.neuropace.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001528287 |
| Description | NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. Additional info from NASDAQ: |
Director Huennekens R Scott 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 041324
Read moreDirector Fischer Frank M 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 000005
Read moreDirector Geiger Uri 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 000003
Read moreDirector Kumar Rakhi 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 000005
Read moreDirector Ryan Renee 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 000002
Read moreDirector Andrade Lisa 🟢 acquired 8.3K shares (1 derivative) of NeuroPace Inc (NPCE) at $15.74 Transaction Date: Jun 05, 2026 | Filing ID: 000002
Read moreDirector Becker Joel 🔴 sold 1.3K shares of NeuroPace Inc (NPCE) at $15.88 Transaction Date: Jun 03, 2026 | Filing ID: 000011
Read moreNeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Read moreNeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Read more